Press Releases Category
Initiation of Phase 1 Clinical Trial for Topical treatment of Acute Skin and Skin Structure Infections
Microbion Corporation, a Montana-based pharmaceutical company focused on development of novel
therapeutics for treatment of bacterial infections, announced today that it has initiated a Phase 1 clinical
trial of the company’s lead topical anti-infective drug product. The double-blind randomized, placebo
controlled study is being conducted at clinical sites in the United Kingdom and will assess safety,
tolerability, and pharmacokinetics…
Download Full Press Release – Microbion Corporation Press Release (07.05.11)
Microbion BioSciences Corporation Part of New Institute Committed to Improved Treatment of War Wounded
Bozeman, Montana – The United States Army Medical Research and Materiel Command (USAMRMC), in conjunction with the Office of Naval Research (ONR), the National Institutes of Health (NIH), the Office of the Air Force of the Surgeon General (AF/SG), and the Department of Veterans Affairs, have awarded $85 million to two consortia which in combination with the US Army Institute of Surgical Research (USAISR), form the Armed Forces Institute of Regenerative Medicine (AFIRM). Overall funding to the consortia from all sources is expected to exceed $250 million over the next five [...]
Read More »